Navigation Links
Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism
Date:5/26/2010

JERUSALEM, May 26, 2010 /PRNewswire-FirstCall/ --

- Study Data Shows ORMD-0801 Resulted in Glucose and C-Peptide Reduction

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that the paper entitled, "Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects," authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published in the Diabetes, Obesity and Metabolism (DOM) journal.

"Publication of our data in a prestigious journal such as DOM lends further credence to the importance of oral insulin as a potential drug in the management of diabetes. The data published on formulation optimization is an important milestone in the development of ORMD-0801, and provides the continued evidence of clinical safety and the foundation for the proof of concept study for our proprietary oral drug delivery platform," said Dr. Miriam Kidron, Chief Officer of Oramed.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials. Establish
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
2. Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
3. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
4. Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
5. Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
6. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
7. Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist
8. Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
9. Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)
10. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
11. Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... According to Jeff Howell, Partner of Nidea ... new development in Downtown Toronto is expanding at a ... 755 storeys of new development last week (including three ... dominating the Toronto skyline for the foreseeable future in ... for new development. , As the Toronto city council ...
(Date:9/15/2014)... 16, 2014 Cancer Immunotherapy ... Adoptive T-cell Therapies is a new market research ... the three principal types of therapeutics that have ... in cancer immunotherapy (which is often called "immuno-oncology") ... and Adoptive cellular immunotherapy. , The regular ...
(Date:9/15/2014)... fast when a patient has sepsis, a life-threatening condition ... blood -- often too fast for antibiotics to help. ... developed by a team at Harvard,s Wyss Institute for ... treat sepsis. , "Even with the best current ... at least 30 percent of the time," said Mike ...
(Date:9/15/2014)... , Sept. 15, 2014 Zymo ... viral transport solution for safe ambient temperature storage ... molecular testing. Importantly, the infectivity of agents in such ... maintaining the integrity of the viral nucleic acids ... the recent Ebola epidemic in West ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3
... interpersonal skills, influence and collaboration, but when it comes right ... that runs right down the middle. As director of the ... Annie Stunden manages 500 staff. But because there ... in other departments on campus, a traditional chain of command ...
... looked at venture capital performance in the U.S. during 2004. , ... garnered its share of this investment as well as how the ... a more detailed look at how the life science industry in ... PricewaterhouseCoopers MoneyTree report. , ,Still, I was able to ferret ...
... the university's Center for Intelligent Maintenance Systems said ... in April. Professor Jay Lee told the Milwaukee Journal-Sentinel that ... not have good enough legal and other infrastructure to support ... said it would sell all the assets of its ...
Cached Biology Technology:Annie Stunden, CIO at the University of Wisconsin-Madison 2Annie Stunden, CIO at the University of Wisconsin-Madison 3Annie Stunden, CIO at the University of Wisconsin-Madison 4Midwest VC investment up in 2004, but number of deals down 2Midwest VC investment up in 2004, but number of deals down 3
(Date:9/16/2014)... GARDENS, Fla. , Sept. 16, 2014 /PRNewswire/ ... biometric identity management solutions, announced today the launch ... designed to authenticate the identity of an individual ... The Android-based Verifier Sentry rapidly reads credential documents ... holder,s ID by matching the biometric to a ...
(Date:9/16/2014)... foods, autumn harks a season of bounty. Fungi of ... collectors to woodlands in search of elusive but delectable ... allure of the treasure hunt, and their mysterious not-quite-meat, ... are the mushrooms which you are eating known to ... vastly underdocumented although some estimates range up to ...
(Date:9/15/2014)... so-called central dogma of molecular biologythat DNA makes ... explanation for how genetic information is deciphered and ... of course, the process is vastly more complicated ... ago by Nobel Laureate Francis Crick, co-discoverer of ... multiple types of RNA, three of whichmessenger RNA ...
Breaking Biology News(10 mins):Cross Match Launches New Identity Management Handheld Solution 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 3Scientists discover RNA modifications in some unexpected places 2
... MD, MPH, has been named the winner of the $100,000 ... 6,500 online votes from people across the globe determined the ... sequencing of newborns, emerged as the winner after six weeks ... for creating this competition and I am delighted to win. ...
... Columbia University Medical Center (CUMC) presented the 2012 ... Diane Mathis, PhD, both of Harvard Medical School, for ... underlying type 1 diabetes over the past three decades. ... Center, is Columbia,s top honor for excellence in diabetes ...
... has been 25 years since the identification of two proteins ... that revealed a group of related proteins. In recognition ... has published a series of articles that assess what we ... that research is headed. This superfamily was recognized in ...
Cached Biology News:Research gets real - Public votes determine winner of $100,000 research prize 2Columbia awards 2012 Naomi Berrie Award to Drs. Christophe Benoist & Diane Mathis 2Columbia awards 2012 Naomi Berrie Award to Drs. Christophe Benoist & Diane Mathis 3The Journal of Biological Chemistry commemorates an important 1987 discovery 2
... The ApopTag Fluorescein Direct ... detects apoptotic cells in situ ... The DNA fragments are tagged ... nucleotide. The kit provides fluorescence ...
... two color staining method for labeling DNA ... apoptotic cells by flow cytometry. The kit ... measuring apoptosis in cells including: positive and ... washing, reaction and rinsing buffers for processing ...
... and PowerPac 3000 system, 220-240 V, is used ... 50 cm vertical slab gel format. The system ... is capable of separating nucleic acids with single ... (IPC) assembly (IPC and bonded inner glass plate, ...
... agarose is used for second-dimension SDS-PAGE ... in place in PROTEAN Plus cells. ... to allow monitoring of electrophoresis runs. ... agarose in 1x Tris, glycine, SDS, ...
Biology Products: